Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shafer

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Nature Communications|November 18, 2018
Demographic histories and genetic diversity across pinnipeds are shaped by human exploitation, ecology and life-historyM A Stoffel, E Humble, A J Paijmans, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitorP E Sanderson, K J Cutrona, B D Dorsey, et al.
Journal of Medicinal Chemistry|November 26, 1997
Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 positionD M Feng, S J Gardell, S D Lewis, et al.
Nature Ecology & Evolution|June 10, 2020
Determinants of genetic variation across eco-evolutionary scales in pinnipedsClaire R Peart, Sergio Tusso, Saurabh D Pophaly, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffoldPhilippe G Nantermet, Christopher S Burgey, Kyle A Robinson, et al.
Journal of Medicinal Chemistry|November 7, 1998
Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templatesP E Sanderson, T A Lyle, K J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamidesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Journal of Medicinal Chemistry|February 7, 2003
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridinesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Trends in Ecology & Evolution|December 24, 2014
Genomics and the challenging translation into conservation practiceAaron B A Shafer, Jochen B W Wolf, Paulo C Alves, et al.
The New Phytologist|August 14, 2020
Integrating the evidence for a terrestrial carbon sink caused by increasing atmospheric CO<sub>2</sub>Anthony P Walker, Martin G De Kauwe, Ana Bastos, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Nature Communications|November 18, 2018
Demographic histories and genetic diversity across pinnipeds are shaped by human exploitation, ecology and life-historyM A Stoffel, E Humble, A J Paijmans, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitorP E Sanderson, K J Cutrona, B D Dorsey, et al.
Journal of Medicinal Chemistry|November 26, 1997
Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 positionD M Feng, S J Gardell, S D Lewis, et al.
Nature Ecology & Evolution|June 10, 2020
Determinants of genetic variation across eco-evolutionary scales in pinnipedsClaire R Peart, Sergio Tusso, Saurabh D Pophaly, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
P2 pyridine N-oxide thrombin inhibitors: a novel peptidomimetic scaffoldPhilippe G Nantermet, Christopher S Burgey, Kyle A Robinson, et al.
Journal of Medicinal Chemistry|November 7, 1998
Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templatesP E Sanderson, T A Lyle, K J Cutrona, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamidesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Journal of Medicinal Chemistry|February 7, 2003
Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridinesChristopher S Burgey, Kyle A Robinson, Terry A Lyle, et al.
Trends in Ecology & Evolution|December 24, 2014
Genomics and the challenging translation into conservation practiceAaron B A Shafer, Jochen B W Wolf, Paulo C Alves, et al.
The New Phytologist|August 14, 2020
Integrating the evidence for a terrestrial carbon sink caused by increasing atmospheric CO<sub>2</sub>Anthony P Walker, Martin G De Kauwe, Ana Bastos, et al.
Pageof 29